Share this article

Cardiovascular devices are used in treating diseases related to the heart and the circulatory system. A peripheral vascular stent is an expandable perforated tube which is inserted into a peripheral vessel to prevent blood flow constriction. GlobalData uses proprietary data and analytics to provide a comprehensive report on the peripheral vascular stents market in New Zealand. Buy the latest report here.

In 2022, GlobalData’s Market Model methodology determined that the leading player in the peripheral vascular stents market in New Zealand was Abbott Laboratories followed by Becton Dickinson and Co, Biotronik SE & Co, Boston Scientific, Cardinal Health, Cook Medical, Getinge, Medtronic, Terumo and W. L. Gore & Associates.

Understanding market size can be crucial to evaluate opportunities and make informed decisions about market entry and exit. Medical device companies can identify attractive segments in respective markets as well as develop marketing strategies based on forecasts for those segments.

Bare metal stents (BMS), drug eluting stents (DES), covered stents and bio-absorbable stents are covered under this segment. A stent refers to a stent delivery system. Peripheral bare metal stents is a mesh-such as tube structured thin wire without coating. A drug eluting stent is a mesh-such as tube structured thin wire present with a coating of drug or medicine which helps in preventing the arteries from re-stenosis. Peripheral Covered stents is a flexible tube used to repair or support a damaged section of an artery. A peripheral bioabsorbable stents is manufactured from a bio-absorbable material that might get dissolved or absorbed in the body.

The peripheral vascular stents market in New Zealand can expand or contract due to a variety of reasons including population demographics, disease incidence and prevalence, macroeconomic issues, and geopolitical considerations. Disruption to a market could be caused by a sudden, unexpected change in these factors, but it could also be driven by changes in clinical practice, leading to a change in diagnosis or treatment of patients, as part of a process to generally improve medical practice.

For the latest analysis of the market size peripheral vascular stents in New Zealand, buy the report here.

Premium Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData’s Medical Intelligence Center Market Models are the gold standard of medical device market valuation, company share estimation and market trend forecasting. GlobalData uses a patient-based forecast model or installed base methodology to determine the market size for therapeutic indications and capital equipment expenditures. Estimates are based on a number of sources, including primary research—KOL and industry contact interviews—and secondary research, such as company reports, press releases, published articles, proprietary databases, and general news media.